During the COVID-19 pandemic, MyMyelomaTeam will provide summaries and links to articles of importance to people living with myeloma. This page will be updated with information as it becomes available.
MyMyelomaTeam, October 5, 2021
The Centers for Disease Control and Prevention (CDC) also has recommended Pfizer COVID-19 vaccine booster shots for adults over 65 and other high-risk individuals at least six months after their second dose. People with multiple myeloma currently may be eligible for a third dose of the Pfizer and Moderna COVID-19 vaccine at least 28 days after their initial two doses.
MyMyelomaTeam, June 15, 2021
As of June 14, 2021, more than 64 percent of Americans had received at least their first vaccination against COVID-19. MyMyelomaTeam members who have been vaccinated are eagerly sharing their hopes and plans now that vaccination has lowered their risk for experiencing serious illness from the potentially deadly virus.
MyMyelomaTeam, February 25, 2021
In January 2021, the National Cancer Center Network (NCCN) issued recommendations stating that people with cancer, including those receiving active therapy, should receive the COVID-19 vaccine as soon as it becomes available to them. MyMyelomaTeam invited Dr. Matt Kalaycio, a board-certified hematologist and a professor at the Cleveland Clinic Lerner College of Medicine, to help us address questions that many members have about the vaccine.
MyMyelomaTeam, November 20, 2020
The 2020 fall and winter holiday season will be different than any in our lifetimes. While multiple myeloma may have complicated holiday celebrations in the past, COVID-19 introduces a brand new set of limitations.
MyMyelomaTeam, May 12, 2020
MyMyelomaTeam, April 14, 2020
MyMyelomaTeam, March 20, 2020
Other COVID-19 Resources
Easily manage your subscription from the emails themselves.